The SLC52A1 gene helps your body move riboflavin, also called vitamin B2, into cells so they can make energy and support normal growth. If this gene does not work well, cells may not get enough riboflavin, which can lead to low energy supply and problems in parts of the body that need it most. In some families, harmful variants in the SLC52A1 gene have been linked to riboflavin deficiency, especially during pregnancy, and can contribute to illness in a newborn. This gene is not widely known outside medical genetics.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the directions for producing proteins, the parts of cells that do much of the work. Other genes mostly control when certain processes happen, where they take place, and how strongly they occur. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
SLC52A1Gene function
What if the gene works
The SLC52A1 gene helps move riboflavin (vitamin B2) into cells. This supports energy production and other everyday cell functions.
Risk
What if the gene does not work
Variants in the SLC52A1 gene can lower riboflavin transport and cause riboflavin deficiency. Milder to more severe variants may cause anemia in pregnancy and, in newborns, low blood sugar, high ammonia, or a temporary to severe metabolic illness.
Treatment
What does that mean for your treatment
No treatment or drug choice plan specific to the SLC52A1 gene is currently established in clinical guidelines. Published reports suggest riboflavin supplements may help some people with problems linked to variants in the SLC52A1 gene, especially during pregnancy and early infancy, but this is not yet a standardized gene specific approach.
Conditions associated with SLC52A1
Gene function
What if the gene works
Your cells need a steady supply of vitamin B2 to turn food into usable energy and keep many enzymes working. The SLC52A1 gene helps move this vitamin, also called riboflavin, across cell membranes so it can reach the places that need it. This supports normal everyday cell activity throughout the body.
The SLC52A1 gene makes a transporter that moves riboflavin (vitamin B2) through the cell membrane. This lets cells take in the vitamin they need for normal daily work.
This transporter helps riboflavin move between body compartments so the vitamin can be distributed where it is needed. This is a key part of how the SLC52A1 gene helps your body use vitamin B2.
Once inside cells, riboflavin can be changed into active helper forms that many enzymes use. These helpers support energy release from food and other routine cell processes.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC52A1 gene can weaken how well its riboflavin transporter is made, folded, or moved to the cell surface, which lowers riboflavin uptake into cells. In how SLC52A1 gene variants affect protein function, milder changes may leave some transport activity, while more severe variants can greatly reduce it or stop it altogether. Some variants change a single protein building block, while others cut the transporter short and make it unstable.
How variants are linked to conditions
When doctors assess how variants in the SLC52A1 gene are linked to conditions, the main confirmed association is riboflavin transporter deficiency 1. Pathogenic variants can cause low riboflavin levels and related problems, including anemia in some adults. In certain pregnancies, these variants have also been linked to a temporary newborn illness soon after birth.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widespread in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a part. In other situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC52A1 gene. When SLC52A1 is linked to symptoms, risk is usually driven mainly by the inherited gene change rather than lifestyle factors, and personal guidance can help put that result in context.
Inheritance of SLC52A1 variants
Current evidence does not support one broadly confirmed Mendelian pattern for how SLC52A1 gene variants are inherited across all reported SLC52A1 related findings, because the clinical picture can depend on the specific variant and family context. In practice, discussions of how SLC52A1 gene variants are inherited are often individualized rather than summarized with a single dominant or recessive rule. The SLC52A1 gene is located on chromosome 17, which is an autosome. That means each person inherits one copy of the SLC52A1 gene from each parent.
What does my SLC52A1 result mean for my family?
For SLC52A1, the family pattern that is best described is dominant, which means close relatives may also carry the same gene change. Parents, brothers, sisters, and children may want to review the result with a genetics specialist, especially in families with low riboflavin levels or babies who had feeding, breathing, or low blood sugar problems soon after birth. This gene can be especially important in pregnancy because a mother’s result may affect a newborn.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the SLC52A1 gene, doctors use genetic testing for SLC52A1 variants on a blood or saliva sample. The lab reads the gene’s DNA and looks for variants, then reports whether a finding is linked to disease, likely harmless, or still unclear.
When should I consider getting a genetic test?
Genetic testing for the SLC52A1 gene may be considered if a newborn has unexplained low vitamin B2 (riboflavin), feeding problems, weakness, or blood test changes that suggest trouble using riboflavin. It may help explain a rare inherited condition, especially if similar problems happened in pregnancy or run in the family.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal depends on the condition and on the type of variant involved. Over time, many factors influence how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body absorbs, breaks down, or responds to medicines. This helps explain why the same treatment works well for one person, seems less effective in another, or causes more side effects in someone else. These differences are common and can influence both how strongly a medicine works and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape a person’s response to medications. By looking at connections between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can affect how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the SLC52A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about side effects, supplements, or how a treatment is working, talk with your doctor.
History
SLC52A1 entered the genetics literature as scientists worked to identify the body’s riboflavin transport genes in the late 2000s. Initially understood only through visible traits, later recognized as tied to a specific gene, it was first studied under another name before being reclassified as SLC52A1 as its role became clearer. From these first observations, research expanded steadily, linking changes in this gene to rare inherited problems with riboflavin transfer, including cases affecting newborns. This helped connect earlier unexplained family patterns with a defined genetic cause. Over time, descriptions became more precise, and SLC52A1 found its place within a small group of riboflavin transporter genes that shaped modern understanding of these conditions.